Zhang J, Chiodo L A, Freeman A S
Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 48201.
Synapse. 1993 Dec;15(4):276-84. doi: 10.1002/syn.890150404.
Further evaluation of the effects of BMY 14802 on dopamine (DA) neuronal activity in the rat substantia nigra pars compacta (A9) was conducted with single-unit recording and microiontophoresis in anesthetized rats. Microiontophoretic administration of BMY 14802 (sigma, serotonin (5-HT)-1A and alpha-1 adrenoceptor ligand) had no effect on DA neurons. Microiontophoretic administration of (+)-3-PPP (weak D2 agonist with high affinity for sigma receptors) and quinpirole (D2/D3 agonist) inhibited A9 DA neuronal activity. Co-iontophoresis or i.v. pretreatment with BMY 14802 had no effect on the current-response curves for the effects of microiontophoretic (+)-3-PPP or quinpirole on A9 DA neurons. Co-iontophoretic administration of (-)-sulpiride, a selective D2 antagonist, blocked the inhibitory effects of microiontophoretic (+)-3-PPP. The effects of BMY 14802 (0.25-8 mg/kg, i.v.) on DA neurons (increased firing rate, increased burst-firing, reduced regularity of firing pattern) were not altered by acute brain hemitransection, but were blocked by pretreatment with NAN-190, an antagonist of 5-HT-1A and alpha-1 receptors. The alpha-1 receptor antagonist, prazosin, did not block these effects of BMY 14802. In conclusion, the effects of BMY 14802 on DA neuronal firing rate and firing pattern are indirect, perhaps due in part to the occupation of 5-HT-1A receptors.
通过对麻醉大鼠进行单单位记录和微离子透入法,进一步评估了BMY 14802对大鼠黑质致密部(A9)多巴胺(DA)神经元活动的影响。微离子透入法给予BMY 14802(西格玛、5-羟色胺(5-HT)-1A和α-1肾上腺素能受体配体)对DA神经元无影响。微离子透入法给予(+)-3-PPP(对西格玛受体具有高亲和力的弱D2激动剂)和喹吡罗(D2/D3激动剂)可抑制A9 DA神经元活动。与BMY 14802进行共离子透入或静脉预处理,对微离子透入法给予(+)-3-PPP或喹吡罗对A9 DA神经元的作用的电流-反应曲线无影响。共离子透入给予选择性D2拮抗剂(-)-舒必利可阻断微离子透入法给予(+)-3-PPP的抑制作用。急性脑半横断并未改变BMY 14802(0.25-8毫克/千克,静脉注射)对DA神经元的作用(增加放电频率、增加爆发性放电、降低放电模式的规律性),但可被5-HT-1A和α-1受体拮抗剂NAN-190预处理所阻断。α-1受体拮抗剂哌唑嗪并未阻断BMY 14802的这些作用。总之,BMY 14802对DA神经元放电频率和放电模式的作用是间接的,可能部分归因于对5-HT-1A受体的占据。